1. Background
2. Objectives
3. Patients and Methods
3.1. Study Design, Study Setting, and Study Population
3.2. Informed Consent, Ethical Clearance, Official Permission
3.3. Training and Calibration
3.4. Inclusion Criteria Subjects
3.5. Exclusion Criteria
3.6. Proforma Details
3.6.1. Data Collection
3.7. Statistical Analysis
4. Results
| Variables | Adverse Habits n (%) | No Habits | Total | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Smoking Tobacco | Smokeless Tobacco | Other (Alcohol) | Combination of Habits | ||||||||
| Cigarette | Cigar | Water Pipe | European Pipe | Bidi | Arecanut | Tobacco | |||||
| Gender | |||||||||||
| Male | 4 (3.9) | 0 | 3 (2.9) | 0 | 34 (33.3) | 6 (5.8) | 10 (9.8) | 15 (14.7) | 28 (27.4) | 2 (1.9) | 102 (86.4) |
| Female | 0 | 0 | 0 | 0 | 2 (12.5) | 6 (37.5) | 4 (25) | 0 | 0 | 4 (25) | 16 (13.6) |
| Age, y | |||||||||||
| 17-26 | 2 (7.4) | 0 | 1 ( 3.7) | 0 | 7 (25.9) | 3 (11.1) | 4 (14.8) | 2 (7.4) | 6 (22.2) | 2 (7.4) | 27 (22.8) |
| 27-36 | 0 | 0 | 1 (2.3) | 0 | 1 (30.2) | 5 (11.6) | 5 (11.6) | 7 (16.2) | 11 (25.5) | 1 (2.3) | 43 (36.4) |
| 37-46 | 1 (4) | 0 | 1 (4) | 0 | 5 (20) | 3 (12) | 2 (8) | 3 (12) | 9 (36) | 1 (4) | 25 (21.1) |
| 47-56 | 0 | 0 | 0 | 0 | 4 (36.3) | 0 | 3 (27.2) | 2 (18.1) | 1 (9) | 1 (9) | 11 (9.3) |
| > 56 | 1 (8.3) | 0 | 0 | 0 | 7 (58.3) | 1 (8.3) | 0 | 1 (8.3) | 1 (8.3) | 1 (8.3) | 12 (10.1) |
| Total | 4 (3.3) | 0 | 3 (2.5) | 0 | 36 (30.5) | 12 (10.1) | 14 (11.8) | 15 (12.7) | 28 (23.7) | 6 (5) | 118 (100) |
| Oral Lesions | Age Group (Years) n (%) | Gender n (%) | Total (n = 118) n (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 17 - 26 (n = 27) | 27 - 36 (n=43) | 37 - 46 (n = 25) | 47 - 56 (n = 11) | > 56 (n = 12) | p value | Male (n = 102) | Female (n = 16) | P Valuea | ||
| Leukoplakia | 0 | 5 (11.6) | 5 (20) | 1 (9) | 0 | 0.001b | 8 (7.8) | 3 (18.7) | 0.001b | 11 (9.3) |
| Erythroplakia | 0 | 0 | 1 (4) | 0 | 0 | 0.331 | 1 (0.9) | 0 | 0.790 | 1 (0.8) |
| Lichen planus | 0 | 1 (2.3) | 0 | 1 (9) | 0 | 0.212 | 2 (1.9) | 0 | 0.345 | 2 (1.6) |
| Oral submucousfibrosis | 0 | 1 (2.3) | 0 | 0 | 0 | 0.331 | 1 (0.9) | 0 | 0.999 | 1 (0.8) |
| Candidiasis | 4 (14.8) | 10 (23.2) | 4 (16) | 1 (9) | 0 | 0.001b | 16 (15.6) | 3 (18.7) | 0.001b | 19 (16.1) |
| Recurrent apthae | 0 | 3 (6.9) | 2 (8) | 1 (9) | 0 | 0.001b | 5 (4.9) | 1 (6.2) | 0.001b | 6 (5) |
| Other lesions | 6 (22.2) | 13 (30.2) | 11 (44) | 7 (63.6) | 4 (33.3) | 0.001b | 32 (31.3) | 9 (56.2) | 0.001b | 41 (34.7) |
| Total lesions | 6 (22.2) | 31 (72.1) | 20 (80) | 7 (63.6) | 4 (33.3) | 0.001b | 60 (58.8) | 9 (56.2) | 0.001b | 69 (58.4) |
aTest applied: the chi-square test.
bP ≤ 0.05 was set as statistically significant.
| Oral Lesions | Adverse Habits n (%) | Total (n = 118) | |||||
|---|---|---|---|---|---|---|---|
| Smoking Tobacco (n = 43) | Smokeless Tobacco (n = 26) | Other (Alcohol) (n = 15) | Combination of Habits (n = 28) | No Habits (n = 6) | P Valuea | ||
| Leukoplakia | 4 (9.3) | 2 (7.6) | 0 | 5 (17.8) | 0 | 0.04b | 11 (9.3) |
| Erythroplakia | 0 | 0 | 0 | 1 (3.5) | 0 | 0.18 | 1 (0.8) |
| Lichen planus | 0 | 1 (3.8) | 1 (6.6) | 0 | 0 | 0.11 | 2 (1.6) |
| Oral submucous fibrosis | 0 | 1 (3.8) | 0 | 0 | 0 | 0.18 | 1(0.8) |
| Candidiasis | 3 (6.9) | 5 (19.2) | 1(6.6) | 10 (35.7) | 0 | 0.05b | 19 (16.1) |
| Recurrent apthae | 1 (2.3) | 0 | 1 (16.6) | 2 (7.1) | 2 (33.3) | 0.07 | 6 (5) |
| Other lesions | 18 (41.8) | 9 (34.6) | 3 (20) | 9 (32.1) | 2 (4.8) | 0.02b | 41 (34.7) |
| Total lesions | 18 (41.8) | 14 (53.8) | 6 (40) | 27 (96.4) | 4 (66.6) | - | 69 (58.4) |
aTest applied: the chi-square test.
bP ≤ 0.05 was set as statistically significant.
| Oral Mucosal Lesions | Duration of Habits n (%) | |||
|---|---|---|---|---|
| < 5 Years (n = 31) | 5-10 Years (n = 32) | > 10 Years (n = 49) | P Valuea | |
| Leukoplakia (n = 11) | 0 | 4 (12.5) | 7 (14.2) | 0.04b |
| Erythroplakia (n = 1) | 0 | 0 | 1 (2) | 0.21 |
| Lichen planus (n = 2) | 0 | 0 | 2 (4) | 0.16 |
| Oral submucous fibrosis (n = 1) | 0 | 0 | 1 (2) | 0.21 |
| Candidiasis (n = 19) | 3 (9.6) | 5 (15.6) | 11 (22.4) | 0.02b |
| Recurrent apthae (n = 6) | 3 (9.6) | 2 (6.2) | 1 (2) | 0.23 |
| Other lesions (n = 41) | 7 (22.5) | 12 (37.5) | 22 (44.8) | 0.03b |
| Total lesions (n = 69) | 9 (29) | 19 (59.3) | 41 (83.6) | 0.02b |
aTest applied: thechi-square test.
bP ≤ 0.05 was set as statistically significant.